Texting your way to quit smoking: telegram bot tested in heart patients

NCT ID NCT07230249

Not yet recruiting Disease control Sponsor: ITMO University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study tests whether a 6-month program delivered through the Telegram messaging app can help people stop smoking after a heart attack. 142 adult smokers who use Telegram will either get the chatbot support or standard advice. The goal is to see if more people quit with the chatbot's help.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Telegram-based behavioral support program
What this could lead to: If it works, this could provide a simple, scalable way to help heart attack survivors quit smoking, reducing their risk of future heart problems.
What could go wrong: This is a small, early-stage trial with only 142 people. The intervention relies on a messaging app, so it may not work for everyone, and results may not apply to non-Telegram users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOCARDIAL INFARCTION (MI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myocardial infarction nicotine dependence Smoking Cessation Tobacco Use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOCARDIAL INFARCTION (MI) SMOKING CESSATION TOBACCO USE

Contacts and locations

Locations

Ulyanovsk Regional Clinical Hospital

Ulyanovsk, Ulyanovsk Oblast, 432000, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.